Cerevel Therapeutics
CERE
#1975
Rank
S$10.66 B
Marketcap
$58.56
Share price
0.00%
Change (1 day)
105.98%
Change (1 year)

Revenue for Cerevel Therapeutics (CERE)

Revenue in 2024 (TTM): N/A

In 2023 the company made a revenue of N/A a decrease over the revenue in the year 2022 that were of N/A.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Cerevel Therapeutics from 2020 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) N/A
2023 N/A
2022 N/A
2021 N/A
2020 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
S$115.62 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
S$56.04 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
S$15.70 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
S$12.25 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA